product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
NFKB2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
catalog :
PCRP-NFKB2-1E1
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
PCRP-NFKB2-1E1
reactivity :
human
application :
western blot, immunoprecipitation
more info or order :
product information
Internal ID :
9882
Name :
PCRP-NFKB2-1E1
Depositor Name :
Protein Capture Reagents Program, produced by JHU/CDI
Depositor Institution :
National Institutes of Health
Date Deposited :
4/8/14
Allow Hybridoma Distribution :
Yes
Cells Available (legacy) :
Yes
Antigen :
NFKB2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG2b
Isotype for catalog (legacy) :
IgG2b
Positive Tested Species Reactivity :
Human
Species Tested (legacy) :
human
Initial Publication Pubmed ID :
29638227
Collections :
Human,Nucleus,Protein Capture Reagents,Transcription factors
Search Keywords :
Protein Capture Reagents Program, produced by JHU/CDI, NFKB2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100), NFKB2, LYT-10, NF-kB2, p105, p52, Monoclonal, Human, , MIgG2b, Human
Antigen Molecular Weight :
96.75
Gene :
NFKB2
Alternate Gene Name(s) :
LYT-10, NF-kB2, p105, p52
Uniprot ID :
Q00653
Antibody Registry ID :
AB_2618889
Immunogen :
Recombinant protein
Immunogen Sequence :
a.a. 37-329
Clonality :
Monoclonal
Myeloma Strain :
SP2/0-Ag14
Epitope Mapped :
No
Recommended Applications :
Immunoprecipitation,Microarray,Western Blot
Immunoblotting (legacy) :
yes
Depositor Growth Medium :
10% low IgG fetal bovine serum in DMEM with 1x pen/strep
Additional Information :
This antibody has been characterized by the NIH Protein Capture Reagents Program RRID: AB_2618889
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
questions and comments